Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016

Publisher Name :
Date: 12-Oct-2016
No. of pages: 103
Inquire Before Buying

This report

Mainly covers the following product types

- Exenatied

- Liraglutide

- Lixisenatide

- Albiglutide

- Dulaglutide

The segment applications including

- Hospital

- Pharmacy

- Other

Segment regions including (the separated region report can also be offered)

- North America

- Europe

- China

- Asia (Ex. China)

- Other

The players list (Partly, Players you are interested in can also be added)

- Novo Nordisk

- AstraZeneca

- Eli Lily

- GSK

- Sanofi

- Bristol-Myers Squibb

- Amylin

With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016

Table of Contents
1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists
1.1 Definition and Specifications of Glucagon like peptide-1 (GLP-1) agonists
1.1.1 Definition of Glucagon like peptide-1 (GLP-1) agonists
1.1.2 Specifications of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists
1.2.1 Exenatied
1.2.2 Liraglutide
1.2.3 Lixisenatide
1.2.4 Albiglutide
1.2.5 Dulaglutide
1.3 Applications of Glucagon like peptide-1 (GLP-1) agonists
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Industry Chain Structure of Glucagon like peptide-1 (GLP-1) agonists
1.5 Industry Overview and Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists
1.5.1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists
1.5.2 Global Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists
1.6 Industry Policy Analysis of Glucagon like peptide-1 (GLP-1) agonists
1.7 Industry News Analysis of Glucagon like peptide-1 (GLP-1) agonists
2 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.1 Raw Material Suppliers and Price Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.2 Equipment Suppliers and Price Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.3 Labor Cost Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.4 Other Costs Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.5 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.6 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists
3 Technical Data and Manufacturing Plants Analysis of Glucagon like peptide-1 (GLP-1) agonists
3.1 Capacity and Commercial Production Date of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
4 Global Glucagon like peptide-1 (GLP-1) agonists Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Capacity and Growth Rate Analysis
4.2.2 2015 Glucagon like peptide-1 (GLP-1) agonists Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Analysis
4.3.2 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Sales Price
4.4.2 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Gross Margin
4.5.2 2015 Glucagon like peptide-1 (GLP-1) agonists Gross Margin Analysis (Company Segment)
5 Glucagon like peptide-1 (GLP-1) agonists Regional Market Analysis
5.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.1.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.1.2 North America 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.1.4 North America 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.2 Europe Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.2.1 Europe Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.2.2 Europe 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.2.4 Europe 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.3 China Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.3.1 China Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.3.2 China 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.3.4 China 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.4 Asia (Ex. China) Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.4.1 Asia (Ex. China) Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.4.2 Asia (Ex. China) 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Asia (Ex. China) 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.4.4 Asia (Ex. China) 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.5 Other Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.5.1 Other Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.5.2 Other 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Other 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.5.4 Other 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
6 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Segment Market Analysis (by Type)
6.1 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales by Type
6.2 Different Types Glucagon like peptide-1 (GLP-1) agonists Product Interview Price Analysis
6.3 Different Types Glucagon like peptide-1 (GLP-1) agonists Product Driving Factors Analysis
6.3.1 Exenatied Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.2 Liraglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.3 Lixisenatide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.4 Albiglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.5 Dulaglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
7 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
7.3.2 Pharmacy Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
7.3.3 Other Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Glucagon like peptide-1 (GLP-1) agonists
8.1 Novo Nordisk
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Novo Nordisk 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novo Nordisk 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.2 AstraZeneca
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 AstraZeneca 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 AstraZeneca 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.3 Eli Lily
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Eli Lily 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Eli Lily 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.4 GSK
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 GSK 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 GSK 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.5 Sanofi
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Sanofi 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sanofi 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.6 Bristol-Myers Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Bristol-Myers Squibb 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bristol-Myers Squibb 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.7 Amylin
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Amylin 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amylin 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
…
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.2 Europe 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.3 China 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.4 Asia (Ex. China) 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.5 Other 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Glucagon like peptide-1 (GLP-1) agonists Marketing Model Analysis
10.1 Glucagon like peptide-1 (GLP-1) agonists Regional Marketing Model Analysis
10.2 Glucagon like peptide-1 (GLP-1) agonists International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Glucagon like peptide-1 (GLP-1) agonists by Regions
10.4 Glucagon like peptide-1 (GLP-1) agonists Supply Chain Analysis
11 Consumers Analysis of Glucagon like peptide-1 (GLP-1) agonists
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists
12.1 New Project SWOT Analysis of Glucagon like peptide-1 (GLP-1) agonists
12.2 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists
13 Conclusion of the Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016
  • High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023
    Published: 19-Apr-2018        Price: US 5650 Onwards        Pages: 216
    “The global HPAPIsmarket projected to grow at a CAGR of 8.7%”The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.On the......
  • Global Chikungunya Fever Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 112
    This report studies the global Chikungunya Fever Drugs market status and forecast, categorizes the global Chikungunya Fever Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Chikungunya Fever Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x %......
  • Global Ureter Cancer Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 107
    This report studies the global Ureter Cancer Drugs market status and forecast, categorizes the global Ureter Cancer Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Ureter Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 201......
  • Global Beta Catenin Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 102
    This report studies the global Beta Catenin market status and forecast, categorizes the global Beta Catenin market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Beta Catenin market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025. ......
  • Germany Interferon Alpha-2a Biosimilar Market Research Report 2018
    Published: 19-Apr-2018        Price: US 3400 Onwards        Pages: 99
    The global Interferon Alpha-2a Biosimilar market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Germany plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Interferon Alpha-2a Biosimilar development status and future trend in Germany, focuses on top players in......
  • Global Guillain-Barre Syndrome Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 102
    This report studies the global Guillain-Barre Syndrome Drugs market status and forecast, categorizes the global Guillain-Barre Syndrome Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Guillain-Barre Syndrome Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, wit......
  • Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 101
    This report studies the global Resistant Pseudomonas Aeruginosa Infections Drugs market status and forecast, categorizes the global Resistant Pseudomonas Aeruginosa Infections Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Resistant Pseudomonas Aeruginosa Infections Drugs market size was xx million US$ and it......
  • Global Ambient Lighting Software Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 103
    This report studies the global Ambient Lighting Software market status and forecast, categorizes the global Ambient Lighting Software market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Ambient Lighting Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of ......
  • Global Rapamune (Sirolimus) Sales Market Report 2018
    Published: 19-Apr-2018        Price: US 4000 Onwards        Pages: 109
    This report studies the global Rapamune (Sirolimus) market status and forecast, categorizes the global Rapamune (Sirolimus) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Rapamune (Sirolimus) market size was xx million US$ and it is expected to reach xx million US$ by ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs